Tekla Capital Management LLC quarter change: USA Stocks, Unchanged
In share positions in stocks (listed in the US), from the quarter ended 2016-06-30 to 2016-09-30, Tekla Capital Management LLC opened 7 positions, added to 10, reduced 15, sold out of 1 and left 34 unchanged. The largest increase in value was BIIB (+$41,943,000); the largest decrease was HCA (-$18,561,000).
- INCY: Country of operation United States; Class Common; Shares 2016-06-30 880,461; Shares 2016-09-30 880,461.
- PBYI: Country of operation United States; Class Common; Shares 2016-06-30 260,200; Shares 2016-09-30 260,200.
- REGN: Country of operation United States; Class Common; Shares 2016-06-30 154,266; Shares 2016-09-30 154,266.
- CTMX: Country of operation United States; Class Common; Shares 2016-06-30 756,090; Shares 2016-09-30 756,090.
Two Form 13F-HR filings compared (SEC CIK 1300336): 2016-06-30 (filed 2016-08-12) and 2016-09-30 (filed 2016-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
| Stock | Country of operation | Class | Shares 2016-06-30 | Shares 2016-09-30 | Share change | Value 2016-06-30 | Value 2016-09-30 | Value change |
|---|
INCY
Incyte Corporation | United States | Common | 880,461 | 880,461 | 0 | $70,419,000 | $83,019,000 | +$12,600,000 |
|---|
PBYI
Puma Biotechnology, Inc. | United States | Common | 260,200 | 260,200 | 0 | $7,751,000 | $17,446,000 | +$9,695,000 |
|---|
REGN
Regeneron Pharmaceuticals, Inc. | United States | Common | 154,266 | 154,266 | 0 | $53,874,000 | $62,018,000 | +$8,144,000 |
|---|
CTMX
CytomX Therapeutics, Inc. | United States | Common | 756,090 | 756,090 | 0 | $7,723,000 | $11,855,000 | +$4,132,000 |
|---|
ALNY
Alnylam Pharmaceuticals, Inc. | United States | Common | 243,995 | 243,995 | 0 | $13,539,000 | $16,538,000 | +$2,999,000 |
|---|
IDXX
IDEXX Laboratories, Inc. | United States | Common | 132,352 | 132,352 | 0 | $12,290,000 | $14,920,000 | +$2,630,000 |
|---|
MRUS
Merus B.V. | | Common | 260,000 | 260,000 | 0 | $2,113,000 | $4,355,000 | +$2,242,000 |
|---|
SBRA
Sabra Health Care REIT, Inc. | United States | Common | 456,190 | 456,190 | 0 | $9,413,000 | $11,487,000 | +$2,074,000 |
|---|
RARE
Ultragenyx Pharmaceutical Inc. | United States | Common | 88,400 | 88,400 | 0 | $4,324,000 | $6,271,000 | +$1,947,000 |
|---|
UHS
Universal Health Services, Inc. | United States | Class B | 134,680 | 134,680 | 0 | $18,061,000 | $16,595,000 | -$1,466,000 |
|---|
DVAX
Dynavax Technologies Corporation | United States | Common | 345,050 | 345,050 | 0 | $5,031,000 | $3,620,000 | -$1,411,000 |
|---|
VRTX
Vertex Pharmaceuticals Incorporated | United States | Common | 1,033,503 | 1,033,503 | 0 | $88,902,000 | $90,132,000 | +$1,230,000 |
|---|
UTHR
United Therapeutics Corporation | United States | Common | 93,100 | 93,100 | 0 | $9,861,000 | $10,993,000 | +$1,132,000 |
|---|
JNJ
Johnson & Johnson | United States | Common | 337,312 | 337,312 | 0 | $40,916,000 | $39,847,000 | -$1,069,000 |
|---|
ZBH
Zimmer Biomet Holdings, Inc. | United States | Common | 102,300 | 102,300 | 0 | $12,315,000 | $13,301,000 | +$986,000 |
|---|
TMO
Thermo Fisher Scientific Inc. | United States | Common | 86,395 | 86,395 | 0 | $12,766,000 | $13,742,000 | +$976,000 |
|---|
NTRA
Natera, Inc. | United States | Common | 882,358 | 882,358 | 0 | $10,646,000 | $9,803,000 | -$843,000 |
|---|
THC
Tenet Healthcare Corporation | United States | Common | 164,500 | 164,500 | 0 | $4,547,000 | $3,728,000 | -$819,000 |
|---|
HALO
Halozyme Therapeutics, Inc. | United States | Common | 200,000 | 200,000 | 0 | $1,726,000 | $2,416,000 | +$690,000 |
|---|
OHI
Omega Healthcare Investors, Inc. | United States | Common | 413,116 | 413,116 | 0 | $14,025,000 | $14,645,000 | +$620,000 |
|---|
ICLR
ICON plc | | Shares | 72,000 | 72,000 | 0 | $5,041,000 | $5,571,000 | +$530,000 |
|---|
FOLD
Amicus Therapeutics, Inc. | United States | Common | 258,000 | 258,000 | 0 | $1,409,000 | $1,909,000 | +$500,000 |
|---|
ESPR
Esperion Therapeutics, Inc. | United States | Common | 102,800 | 102,800 | 0 | $1,016,000 | $1,424,000 | +$408,000 |
|---|
UNH
Unitedhealth Group, Inc. | United States | Common | 331,100 | 331,100 | 0 | $46,751,000 | $46,354,000 | -$397,000 |
|---|
VTR
Ventas, Inc. | United States | Common | 152,491 | 152,491 | 0 | $11,104,000 | $10,770,000 | -$334,000 |
|---|
MCK
McKesson Corporation | United States | Common | 15,000 | 15,000 | 0 | $2,800,000 | $2,501,000 | -$299,000 |
|---|
CYH
Community Health Systems, Inc. | United States | Common | 304,472 | 304,472 | 0 | $3,669,000 | $3,514,000 | -$155,000 |
|---|
XNCR
Xencor, Inc. | United States | Common | 20,000 | 20,000 | 0 | $380,000 | $490,000 | +$110,000 |
|---|
MDRX
Allscripts Healthcare Solutions, Inc. | United States | Common | 173,600 | 173,600 | 0 | $2,205,000 | $2,286,000 | +$81,000 |
|---|
QURE
UniQure NV | | Shares | 241,021 | 241,021 | 0 | $1,776,000 | $1,844,000 | +$68,000 |
|---|
PRGO
Perrigo Company plc | Ireland | Shares | 37,300 | 37,300 | 0 | $3,382,000 | $3,444,000 | +$62,000 |
|---|
RMR
The RMR Group Inc. | United States | Class A | 7,441 | 7,441 | 0 | $230,000 | $282,000 | +$52,000 |
|---|
LTC
LTC Properties, Inc. | United States | Common | 106,212 | 106,212 | 0 | $5,494,000 | $5,522,000 | +$28,000 |
|---|
ABBV
AbbVie Inc. | United States | Common | 156 | 156 | 0 | $10,000 | $10,000 | $0 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |